AbbVie Inc. (ABBV)
NYSE · Healthcare
AbbVie Inc. Long Term Debt 2011–2025
AbbVie Inc. annual long term debt history from 2019 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- AbbVie Inc. long term debt as of December 31, 2025: 64.50B, a 3.50% decrease year-over-year.
- AbbVie Inc. long term debt for 2025 were 64.50B, a 3.50% decrease from 2024.
- AbbVie Inc. long term debt for 2024 were 66.84B, a 12.82% increase from 2023.
- AbbVie Inc. long term debt for 2023 were 59.24B, a 6.15% decrease from 2022.
- AbbVie Inc. long term debt for 2022 were 63.13B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| AbbVie Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $64,503 |
| 2024 | $66,841 |
| 2023 | $59,245 |
| 2022 | $63,128 |
| 2021 | $75,962 |
| 2020 | $84,948 |
| 2019 | $67,233 |
AbbVie Inc. Long Term Debt — FAQ
AbbVie Inc. (ABBV) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABBV's long term debt history?
The chart and table above show AbbVie Inc.'s long term debt by year and by quarter, including the growth rate.